new_0222_0493|RPHM|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0493|RPHM|1|Reneo Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Reneo Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Reneo Pharmaceuticals Inc Inventories (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Reneo Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Reneo Pharmaceuticals Inc Book Value (Quarterly) (USD)|Reneo Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Reneo Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc EV to Revenues|Reneo Pharmaceuticals Inc EV to Earnings|Reneo Pharmaceuticals Inc EV to Free Cash Flow|Reneo Pharmaceuticals Inc EV to Assets (Quarterly)|Reneo Pharmaceuticals Inc PS Ratio|Reneo Pharmaceuticals Inc PE Ratio|Reneo Pharmaceuticals Inc Price to Book Value|Reneo Pharmaceuticals Inc PEG Ratio|Reneo Pharmaceuticals Inc Debt to Equity Ratio|Reneo Pharmaceuticals Inc Dividend Yield|Reneo Pharmaceuticals Inc Shareholder Yield (TTM)|Reneo Pharmaceuticals Inc Percent of Shares Outstanding Short|Reneo Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc Return on Invested Capital|Reneo Pharmaceuticals Inc Quality Ratio Score|Reneo Pharmaceuticals Inc Momentum Score|Reneo Pharmaceuticals Inc Beta (1Y)|Reneo Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Reneo Pharmaceuticals Inc Institutional Investor Ownership Percentage|Reneo Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Reneo Pharmaceuticals Inc Total Employees (Annual)|Reneo Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Reneo Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Reneo Pharmaceuticals Inc Shares Outstanding|Reneo Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Reneo Pharmaceuticals Inc Payout Ratio|Reneo Pharmaceuticals Inc Quick Ratio (Quarterly)|Reneo Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Reneo Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Reneo Pharmaceuticals Inc Effective Tax Rate (TTM)|Reneo Pharmaceuticals Inc Return on Equity|Reneo Pharmaceuticals Inc Net Income (TTM) (USD)|Reneo Pharmaceuticals Inc Revenue (TTM) (USD)|Reneo Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Reneo Pharmaceuticals Inc Revenue (Quarterly) (USD)|Reneo Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Reneo Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Price (USD)|Reneo Pharmaceuticals Inc Total Return Price (USD)|Reneo Pharmaceuticals Inc Enterprise Value (USD)|Reneo Pharmaceuticals Inc 30-Day Average Daily Volume|Reneo Pharmaceuticals Inc 1 Year Price Returns (Daily)|Reneo Pharmaceuticals Inc Short Interest|Reneo Pharmaceuticals Inc PE Ratio (Forward)|Reneo Pharmaceuticals Inc PE Ratio (Forward 1y)|Reneo Pharmaceuticals Inc PS Ratio (Forward)|Reneo Pharmaceuticals Inc PS Ratio (Forward 1y)|Reneo Pharmaceuticals Inc Quarterly EPS Estimates (USD)|Reneo Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|Reneo Pharmaceuticals Inc Quarterly EPS Surprise|Reneo Pharmaceuticals Inc Quarterly Revenue Surprise|Reneo Pharmaceuticals Inc Quarterly Actual EPS (USD)|Reneo Pharmaceuticals Inc Quarterly Actual Revenue (USD)|Reneo Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|Reneo Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|Reneo Pharmaceuticals Inc Price Target (USD)|Reneo Pharmaceuticals Inc Consensus Recommendation|Reneo Pharmaceuticals Inc Price Target Num Estimates|Reneo Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|Reneo Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|Reneo Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|Reneo Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|Reneo Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|Reneo Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|Reneo Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|Reneo Pharmaceuticals Inc Other Properties (Quarterly) (USD)|Reneo Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0493|RPHM|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0493|RPHM|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0493|RPHM|5|91|91||91||91|91|91||91|91||||1.43835616438||||1.43827160494|||1.43835616438||15.3157894737||91|91||||||30.6666666667|91.3333333333|91|91.3333333333|91.3333333333|31.1428571429||91|||91.3333333333|91.4|||91|||||91.3333333333|91.3333333333|91.3333333333|1.43835616438|1.43835616438|1.43835616438|1.44210526316||15.3157894737|||||91.4285714286|91.4285714286|91.5||91.5|91.5|29.7777777778|33.5|31.4444444444|20.2142857143|31.4444444444|24.3636363636|29.7777777778|91.3333333333|91.3333333333|||||91||
new_0222_0493|RPHM|6|3|3||3||3|3|3||3|3||||219||||162|||219||19||3|3||||||9|6|3|6|6|7||3|||6|5|||3|||||6|6|6|219|219|219|190||19|||||7|7|2||2|2|9|8|9|14|9|11|9|6|6|||||3||
new_0222_0493|RPHM|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0493|RPHM|202003||||||||||||||||||||||||||||||||||7.7883||-0.5689|0.924||||||-0.5689|||||||||-4.431|-4.431|0.071||||||||||||||||||||||||3.578|0.009|||||||
new_0222_0493|RPHM|202006||||||||||||||||||||||||||||||||||7.7883||-0.4734|0.882||||||-0.4734|||||||||-3.687|-3.687|0.012||||||||||||||||||||||||2.817|0.009|||||||
new_0222_0493|RPHM|202009||||||||||||||||||||||||||||||||||7.7883||-0.6541|0.668||||||-0.6541|||||||||-5.094|-5.094|0.005||||||||||||||||||||||||4.431|0.009|||||||
new_0222_0493|RPHM|202012|55.025|53.613||0.069||97.336|4.58|92.756||-42.115|-44.958|||||||||||||||0.908||||||||24.2107|23|-0.2583|1.133|||24.2107|||-0.2583||||-19.465|||||-6.253|-6.253|-0.002||||||||||||||||||||||||5.118|0.01|||||0.122||
new_0222_0493|RPHM|202103|93.56|91.221||0.081||144.038|3.93|140.108||-48.717|-52.17||||-11.3268|||||||||1.0356||0.556|||||||25.1632|24.2107|29|-0.2979|1.742|24.2107||24.2107|||-0.2979||||-22.246|||||-7.212|-7.212|0.002|14.4|14.4|257.4131|73164.0667||250715|||||-0.42||-728.5714||-3.48||||31.3333|1.3333|3|-2.9433|-2.4667|5.472|0.01|||||0.144|10.05|
new_0222_0493|RPHM|202106|171.141|167.331||0.085||3.753|3.336|0.417||167.551|-61.386||||-2.0099||||1.3525|||||4.8179||0.434|0.003||||||95.0652|21.3644|29|-0.43|2.949|24.2887||24.2887|||-0.43|-84.639|||-27.775|||||-9.216|-9.216|0.012|9.33|9.33|59.2826|92288.9||1170210|||||-0.3767||-14.1583||-0.43||||31.3333|1.3333|3|-3.21|-3.0067|6.279|0.01|||||0.158|8.19|11.07
new_0222_0493|RPHM|202109|162.665|157.734||0.2||6.735|6.353|0.382||156.208|-74.121||||-0.7196||||1.1641|||||4.7767||1.271|0.003||||||95.4497|24.3968|34|-0.52|3.434|24.4077||24.4077|||-0.52|-0.002|||-35.416|||||-12.735|-12.735|0.017|7.45|7.45|24.1034|122068.7667||1165885|||||-0.42||-23.8095||-0.52||||31.3333|1.3333|3|-3.21|-3.0067|9.318|0.013|||||0.286|6.56|6.88
new_0222_0493|RPHM|202112|||||||||||||||-1.5252||||1.3368|||||1.019|||||||||95.1114||||||||||||||||||||||8.55|8.55|51.0903|72926.6||248870|||||-0.574||||||||33.4|1.4|5|-3.41|-2.98||||||||6.21|4.98
new_0222_0493|RPHM|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.62|||||||||||||||||||||
new_0222_0493|RPHM|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.686|||||||||||||||||||||
new_0222_0493|RPHM|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.728|||||||||||||||||||||
new_0222_0493|RPHM|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.814|||||||||||||||||||||